- Home
- ASTI vs APVO Comparison
ASTI vs APVO Comparison
Compare ASTI & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- APVO
- Stock Information
- Founded
- ASTI 2005
- APVO 2016
- Country
- ASTI United States
- APVO United States
- Employees
- ASTI N/A
- APVO N/A
- Industry
- ASTI Semiconductors
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- APVO Health Care
- Exchange
- ASTI Nasdaq
- APVO Nasdaq
- Market Cap
- ASTI 3.1M
- APVO 3.3M
- IPO Year
- ASTI N/A
- APVO N/A
- Fundamental
- Price
- ASTI $1.68
- APVO $0.67
- Analyst Decision
- ASTI
- APVO Strong Buy
- Analyst Count
- ASTI 0
- APVO 1
- Target Price
- ASTI N/A
- APVO $296.00
- AVG Volume (30 Days)
- ASTI 53.6K
- APVO 8.7M
- Earning Date
- ASTI 05-08-2025
- APVO 05-07-2025
- Dividend Yield
- ASTI N/A
- APVO N/A
- EPS Growth
- ASTI N/A
- APVO N/A
- EPS
- ASTI N/A
- APVO N/A
- Revenue
- ASTI $41,893.00
- APVO N/A
- Revenue This Year
- ASTI N/A
- APVO N/A
- Revenue Next Year
- ASTI N/A
- APVO N/A
- P/E Ratio
- ASTI N/A
- APVO N/A
- Revenue Growth
- ASTI N/A
- APVO N/A
- 52 Week Low
- ASTI $1.17
- APVO $0.60
- 52 Week High
- ASTI $34.00
- APVO $51.06
- Technical
- Relative Strength Index (RSI)
- ASTI 58.20
- APVO 30.74
- Support Level
- ASTI $1.30
- APVO $0.60
- Resistance Level
- ASTI $1.70
- APVO $0.80
- Average True Range (ATR)
- ASTI 0.13
- APVO 0.19
- MACD
- ASTI 0.06
- APVO 0.03
- Stochastic Oscillator
- ASTI 96.23
- APVO 6.97
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.